The case of a 19-year-old male who took 12 grams of Ipomoea sp. seeds for hallucinogenic purposes was reported to our regional addictovigilance center (case 2, Table 1). The patient had a history of anxiety, depression, substance use disorder (cannabis, alcohol, codeine, tramadol) and was being treated with antipsychotics, antidepressants, anxiolytics, hypnotics, and anticholinergics. About 2 hours after intake, he experienced mental confusion, hallucinations, mydriasis, and conjunctival